| answer text |
<p>Clinical commissioning groups are responsible for commissioning diabetes services
for their local populations. They are also expected to take National Institute for
Health and Care Excellence (NICE) guidelines into consideration when making their
decisions. NICE currently recommends not routinely offering self-monitoring of blood
glucose levels for adults with type 2 diabetes unless the person:</p><p> </p><p>-
is on insulin;</p><p>- or there is evidence of hypoglycaemic episodes;</p><p>- or
the person is on medication that may increase their risk of hypoglycaemia while driving
or operating machinery;</p><p>- or the person is pregnant or is planning to become
pregnant.</p><p> </p><p>The evidence base for the benefits and cost-effectiveness
of flash glucose monitoring for people with type 2 diabetes is still developing, and
NICE will continue to monitor the evidence and relevant research.</p><p><strong> </strong></p><p><strong>
</strong></p>
|
 |
